From the managing editor
We are just days away from the UK General Election and the campaigns have been fought with gusto as the party leaders attempt to woo voters.
As expected, the NHS has been a big-ticket item on the election agenda.
Of course for pharma, the election is not just about the NHS but also about the UK business environment, and the role industry and life sciences play in UK plc. With industry faced with continual pricing and reimbursement challenges as well as a cash-constrained healthcare system, the ties between the two couldn’t be starker. It’s not surprising pharma is concerned.
The issue of drug pricing and NHS reimbursement won’t disappear after the election – if anything it could get worse (think Cancer Drugs Fund). And with more expensive rare disease drugs due to hit the market, this debate is set to be a humdinger.
As such, the next government has something of a conundrum on its hands. Can it meet the needs of patients, cure the NHS, as well as sufficiently placate the industry? It’s going to be a balancing act of epic proportions.
We hope whoever is elected is up for the job. Good luck.
To read the latest issue of PharmaTimes Magazine, sign up for a free digital subscription or download our free app via iTunes or Google play.
About PharmaTimes Magazine
PharmaTimes Magazine print and digital versions have a total circulation of 23,184, including 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
PharmaTimes Magazine delivers independent, authoritative and trustworthy content on healthcare issues and topics, through impartial coverage in print and online. It brings together key stakeholders through a strong readership, including pharma and the NHS, by providing balanced and informed opinion and analysis around the key issues, trends and developments affecting today’s fast-moving environment.
PharmaTimes Online News Archive offers unique access to past issues of PharmaTimes Magazine and news elert stories.
©PharmaTimes Magazine 2015. All rights reserved. Material prepared by PharmaTimes Magazine is prohibited for use by third parties and publishers without permission.